Solarvest BioEnergy Inc.
SVSH.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 100.25% | -80.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 100.25% | -80.95% |
| Cost of Revenue | -- | -- | -- | 358.58% | 2,046.88% |
| Gross Profit | -- | -- | -- | -743.90% | -2,386.23% |
| SG&A Expenses | -40.27% | -54.24% | -46.86% | -25.62% | 59.46% |
| Depreciation & Amortization | -40.51% | -33.57% | -32.10% | -38.96% | -39.04% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -56.40% | -68.33% | -67.86% | -28.97% | 3.08% |
| Operating Income | 56.39% | 68.32% | 67.85% | 33.17% | -3.22% |
| Income Before Tax | 52.79% | 67.42% | 67.22% | 34.89% | 4.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 52.79% | 67.42% | 67.22% | 34.89% | 4.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.79% | 67.42% | 67.22% | 34.89% | 4.74% |
| EBIT | 56.39% | 68.32% | 67.85% | 33.17% | -3.22% |
| EBITDA | 57.78% | 70.01% | 69.54% | 32.89% | -5.67% |
| EPS Basic | 53.74% | 68.64% | 68.81% | 39.33% | 11.20% |
| Normalized Basic EPS | 50.35% | 63.43% | 64.21% | 35.15% | 4.08% |
| EPS Diluted | 53.74% | 68.64% | 68.81% | 39.33% | 11.20% |
| Normalized Diluted EPS | 50.35% | 63.43% | 64.21% | 35.15% | 4.08% |
| Average Basic Shares Outstanding | 1.23% | 3.54% | 5.99% | 8.58% | 8.44% |
| Average Diluted Shares Outstanding | 1.23% | 3.54% | 5.99% | 8.58% | 8.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |